tiprankstipranks
Trending News
More News >
Wave Life Sciences Pte. Ltd (WVE)
:WVE
US Market

Wave Life Sciences (WVE) Stock Forecast & Price Target

Compare
650 Followers
See the Price Targets and Ratings of:

WVE Analyst Ratings

Strong Buy
11Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Wave
Life Sciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WVE Stock 12 Month Forecast

Average Price Target

$17.05
▲(145.32%Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Wave Life Sciences in the last 3 months. The average price target is $17.05 with a high forecast of $24.00 and a low forecast of $7.50. The average price target represents a 145.32% change from the last price of $6.95.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","25":"$25","9.25":"$9.25","14.5":"$14.5","19.75":"$19.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.05,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$17.05</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,9.25,14.5,19.75,25],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.52,7.864615384615384,9.209230769230768,10.553846153846154,11.898461538461538,13.243076923076922,14.587692307692308,15.932307692307692,17.276923076923076,18.62153846153846,19.966153846153844,21.310769230769232,22.655384615384616,{"y":24,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.52,7.33,8.14,8.95,9.76,10.57,11.379999999999999,12.19,13,13.81,14.620000000000001,15.43,16.240000000000002,{"y":17.05,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.52,6.595384615384615,6.67076923076923,6.746153846153846,6.821538461538461,6.896923076923077,6.972307692307692,7.047692307692308,7.123076923076923,7.1984615384615385,7.273846153846153,7.349230769230769,7.424615384615384,{"y":7.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.24,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.16,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.74,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.3,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.83,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.27,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.37,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.57,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.57,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.74,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.94,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.25,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.52,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$24.00Average Price Target$17.05Lowest Price Target$7.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on WVE
TipRanks AITipRanks
Not Ranked
TipRanks
$7
Hold
0.72%
Upside
Reiterated
07/05/25
The overall score reflects financial challenges and negative valuation metrics, counterbalanced by neutral technical indicators and positive corporate developments, particularly in clinical advancements and financial runway.
Leerink Partners Analyst forecast on WVE
Joseph SchwartzLeerink Partners
Leerink Partners
$24
Buy
245.32%
Upside
Reiterated
07/02/25
Wave Life Sciences: Promising RNA Editing Developments and Positive Stock Outlook
Wells Fargo Analyst forecast on WVE
Tiago FauthWells Fargo
Wells Fargo
$24
Buy
245.32%
Upside
Reiterated
06/27/25
Wave Life Sciences' WVE-007: Undervalued Potential in Obesity Treatment with Promising Preclinical Results
H.C. Wainwright Analyst forecast on WVE
Andrew FeinH.C. Wainwright
H.C. Wainwright
$22
Buy
216.55%
Upside
Reiterated
06/23/25
Analysts Offer Insights on Healthcare Companies: Cytokinetics (NASDAQ: CYTK), Wave Life Sciences (NASDAQ: WVE) and MannKind (NASDAQ: MNKD)
Wedbush Analyst forecast on WVE
Yun ZhongWedbush
Wedbush
$18
Buy
158.99%
Upside
Reiterated
06/23/25
Analysts Are Bullish on Top Healthcare Stocks: Wave Life Sciences (WVE), Lineage Therap (LCTX)
Cantor Fitzgerald Analyst forecast on WVE
Steven SeedhouseCantor Fitzgerald
Cantor Fitzgerald
$10
Buy
43.88%
Upside
Reiterated
06/22/25
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE), Perspective Therapeutics (NYSE MKT: CATX) and PTC Therapeutics (NASDAQ: PTCT)
Truist Financial Analyst forecast on WVE
Joon LeeTruist Financial
Truist Financial
Buy
Reiterated
06/16/25
Raymond James Analyst forecast on WVE
Martin AusterRaymond James
Raymond James
$14
Buy
101.44%
Upside
Initiated
06/10/25
Wave Life Sciences (WVE) Initiated with a Buy at Raymond James
Mizuho Securities Analyst forecast on WVE
Salim SyedMizuho Securities
Mizuho Securities
$22
Buy
216.55%
Upside
Reiterated
06/09/25
Analysts Offer Insights on Healthcare Companies: Natera (NASDAQ: NTRA) and Wave Life Sciences (NASDAQ: WVE)
AI Firm
$7$7.5
Hold
7.91%
Upside
Reiterated
06/07/25
JonesTrading Analyst forecast on WVE
Catherine NovackJonesTrading
JonesTrading
$20
Buy
187.77%
Upside
Reiterated
05/16/25
We are at ASGCT this week and caught Wave's oral sessions on their siRNA and RNA editing programs.
RBC Capital Analyst forecast on WVE
Luca IssiRBC Capital
RBC Capital
$10$9
Hold
29.50%
Upside
Reiterated
05/08/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Alpha Teknova (NASDAQ: TKNO), Definitive Healthcare Corp (NASDAQ: DH) and Wave Life Sciences (NASDAQ: WVE)
B.Riley Financial Analyst forecast on WVE
Madison ElsaadiB.Riley Financial
B.Riley Financial
$22$19
Buy
173.38%
Upside
Reiterated
04/10/25
Wave Life Sciences price target lowered to $19 from $22 at B. RileyWave Life Sciences price target lowered to $19 from $22 at B. Riley
Jefferies Analyst forecast on WVE
Roger SongJefferies
Jefferies
$26
Buy
274.10%
Upside
Reiterated
03/26/25
Jefferies reiterates Buy Rating on WAVE Life Sciences (WVE)Jefferies analyst Roger Song reiterated a Buy rating and $26.00 price target on WAVE Life Sciences (NASDAQ: WVE).
J.P. Morgan Analyst forecast on WVE
Eric JosephJ.P. Morgan
J.P. Morgan
$20$21
Buy
202.16%
Upside
Reiterated
03/04/25
WAVE Life Sciences (WVE) PT Raised to $21 at JPMorganJPMorgan analyst Eric Joseph raised the price target on WAVE Life Sciences (NASDAQ: WVE) to $21.00 (from $20.00) while maintaining a Overweight rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on WVE
TipRanks AITipRanks
Not Ranked
TipRanks
$7
Hold
0.72%
Upside
Reiterated
07/05/25
The overall score reflects financial challenges and negative valuation metrics, counterbalanced by neutral technical indicators and positive corporate developments, particularly in clinical advancements and financial runway.
Leerink Partners Analyst forecast on WVE
Joseph SchwartzLeerink Partners
Leerink Partners
$24
Buy
245.32%
Upside
Reiterated
07/02/25
Wave Life Sciences: Promising RNA Editing Developments and Positive Stock Outlook
Wells Fargo Analyst forecast on WVE
Tiago FauthWells Fargo
Wells Fargo
$24
Buy
245.32%
Upside
Reiterated
06/27/25
Wave Life Sciences' WVE-007: Undervalued Potential in Obesity Treatment with Promising Preclinical Results
H.C. Wainwright Analyst forecast on WVE
Andrew FeinH.C. Wainwright
H.C. Wainwright
$22
Buy
216.55%
Upside
Reiterated
06/23/25
Analysts Offer Insights on Healthcare Companies: Cytokinetics (NASDAQ: CYTK), Wave Life Sciences (NASDAQ: WVE) and MannKind (NASDAQ: MNKD)
Wedbush Analyst forecast on WVE
Yun ZhongWedbush
Wedbush
$18
Buy
158.99%
Upside
Reiterated
06/23/25
Analysts Are Bullish on Top Healthcare Stocks: Wave Life Sciences (WVE), Lineage Therap (LCTX)
Cantor Fitzgerald Analyst forecast on WVE
Steven SeedhouseCantor Fitzgerald
Cantor Fitzgerald
$10
Buy
43.88%
Upside
Reiterated
06/22/25
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE), Perspective Therapeutics (NYSE MKT: CATX) and PTC Therapeutics (NASDAQ: PTCT)
Truist Financial Analyst forecast on WVE
Joon LeeTruist Financial
Truist Financial
Buy
Reiterated
06/16/25
Raymond James Analyst forecast on WVE
Martin AusterRaymond James
Raymond James
$14
Buy
101.44%
Upside
Initiated
06/10/25
Wave Life Sciences (WVE) Initiated with a Buy at Raymond James
Mizuho Securities Analyst forecast on WVE
Salim SyedMizuho Securities
Mizuho Securities
$22
Buy
216.55%
Upside
Reiterated
06/09/25
Analysts Offer Insights on Healthcare Companies: Natera (NASDAQ: NTRA) and Wave Life Sciences (NASDAQ: WVE)
AI Firm
$7$7.5
Hold
7.91%
Upside
Reiterated
06/07/25
JonesTrading Analyst forecast on WVE
Catherine NovackJonesTrading
JonesTrading
$20
Buy
187.77%
Upside
Reiterated
05/16/25
We are at ASGCT this week and caught Wave's oral sessions on their siRNA and RNA editing programs.
RBC Capital Analyst forecast on WVE
Luca IssiRBC Capital
RBC Capital
$10$9
Hold
29.50%
Upside
Reiterated
05/08/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Alpha Teknova (NASDAQ: TKNO), Definitive Healthcare Corp (NASDAQ: DH) and Wave Life Sciences (NASDAQ: WVE)
B.Riley Financial Analyst forecast on WVE
Madison ElsaadiB.Riley Financial
B.Riley Financial
$22$19
Buy
173.38%
Upside
Reiterated
04/10/25
Wave Life Sciences price target lowered to $19 from $22 at B. RileyWave Life Sciences price target lowered to $19 from $22 at B. Riley
Jefferies Analyst forecast on WVE
Roger SongJefferies
Jefferies
$26
Buy
274.10%
Upside
Reiterated
03/26/25
Jefferies reiterates Buy Rating on WAVE Life Sciences (WVE)Jefferies analyst Roger Song reiterated a Buy rating and $26.00 price target on WAVE Life Sciences (NASDAQ: WVE).
J.P. Morgan Analyst forecast on WVE
Eric JosephJ.P. Morgan
J.P. Morgan
$20$21
Buy
202.16%
Upside
Reiterated
03/04/25
WAVE Life Sciences (WVE) PT Raised to $21 at JPMorganJPMorgan analyst Eric Joseph raised the price target on WAVE Life Sciences (NASDAQ: WVE) to $21.00 (from $20.00) while maintaining a Overweight rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Wave Life Sciences

1 Month
xxx
Success Rate
7/15 ratings generated profit
47%
Average Return
+5.59%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 46.67% of your transactions generating a profit, with an average return of +5.59% per trade.
3 Months
xxx
Success Rate
7/17 ratings generated profit
41%
Average Return
+16.62%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 41.18% of your transactions generating a profit, with an average return of +16.62% per trade.
1 Year
Andrew FeinH.C. Wainwright
Success Rate
11/15 ratings generated profit
67%
Average Return
+30.09%
reiterated a buy rating 18 days ago
Copying Andrew Fein's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +30.09% per trade.
2 Years
xxx
Success Rate
10/15 ratings generated profit
67%
Average Return
+21.93%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +21.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WVE Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
15
17
21
15
13
Buy
5
5
5
3
2
Hold
1
2
3
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
21
24
29
21
17
In the current month, WVE has received 15 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. WVE average Analyst price target in the past 3 months is 17.05.
Each month's total comprises the sum of three months' worth of ratings.

WVE Financial Forecast

WVE Earnings Forecast

Next quarter’s earnings estimate for WVE is -$0.27 with a range of -$0.37 to -$0.10. The previous quarter’s EPS was -$0.29. WVE beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.10% of the time in the same period. In the last calendar year WVE has Outperformed its overall industry.
Next quarter’s earnings estimate for WVE is -$0.27 with a range of -$0.37 to -$0.10. The previous quarter’s EPS was -$0.29. WVE beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.10% of the time in the same period. In the last calendar year WVE has Outperformed its overall industry.

WVE Sales Forecast

Next quarter’s sales forecast for WVE is $14.31M with a range of $0.00 to $36.99M. The previous quarter’s sales results were $9.18M. WVE beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year WVE has Outperformed its overall industry.
Next quarter’s sales forecast for WVE is $14.31M with a range of $0.00 to $36.99M. The previous quarter’s sales results were $9.18M. WVE beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year WVE has Outperformed its overall industry.

WVE Stock Forecast FAQ

What is WVE’s average 12-month price target, according to analysts?
Based on analyst ratings, Wave Life Sciences Pte. Ltd’s 12-month average price target is 17.05.
    What is WVE’s upside potential, based on the analysts’ average price target?
    Wave Life Sciences Pte. Ltd has 145.32% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is WVE a Buy, Sell or Hold?
          Wave Life Sciences Pte. Ltd has a consensus rating of Strong Buy which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Wave Life Sciences Pte. Ltd’s price target?
            The average price target for Wave Life Sciences Pte. Ltd is 17.05. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $24.00 ,the lowest forecast is $7.50. The average price target represents 145.32% Increase from the current price of $6.95.
              What do analysts say about Wave Life Sciences Pte. Ltd?
              Wave Life Sciences Pte. Ltd’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of WVE?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis